The Problem of Restrictive Thrombectomy Trial Eligibility Criteria
- 1 September 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (9) , 2988-2990
Abstract
Since 2015, a series of endovascular trials transformed the management of patients with large vessel occlusion stroke. Most thrombectomy trials used restrictive eligibility criteria to optimize the chances of showing that thrombectomy could work. The problem arises when generalizing trial results into evidence-based recommendations. Many organizations, oblivious of this problem, translated verbatim restrictive trial eligibility criteria into authoritative guidelines, which limit the use of thrombectomy to highly selected patients. The clinical problem becomes as follows: what to do for all other stroke patients equally in need of care? The cycle of restrictive trial eligibility criteria, corresponding restrictive guidelines, observational studies of unvalidated practices showing other patients benefit, a new trial is needed, has been repeated often. Thrombectomy trials ought to have included all patients that could potentially benefit. If the signal that was looked for by restricting eligibility is at risk of being lost in the noise generated by the heterogeneity of patients, D. Sackett proposed a solution: to use the same criteria, not to select some patients and exclude others but to prespecify the subgroup of patients most likely to benefit. In this commentary, we propose a tiered approach, where the boundaries of treatment beneficiaries can be more rigorously tested and confirmed. Identification of these patients before the development of guidelines, which would have otherwise neglected these individuals, may open innumerable treatment opportunities to those who will instead be denied of them.Keywords
This publication has 16 references indexed in Scilit:
- Impact of Age and Alberta Stroke Program Early Computed Tomography Score 0 to 5 on Mechanical Thrombectomy Outcomes: Analysis From the STRATIS RegistryStroke, 2021
- Thrombectomy for Primary Distal Posterior Cerebral Artery Occlusion StrokeJAMA Neurology, 2021
- Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery OcclusionStroke, 2020
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationStroke, 2019
- European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE)European Stroke Journal, 2019
- The 2018 ter Brugge Lecture: Problems with the Introduction of Innovations in Neurovascular CareCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2019
- Indications for the Performance of Intracranial Endovascular Neurointerventional Procedures: A Scientific Statement From the American Heart AssociationCirculation, 2018
- A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic StrokeNew England Journal of Medicine, 2001
- Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe StenosisNew England Journal of Medicine, 1998
- Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid StenosisNew England Journal of Medicine, 1991